n803
Showing 1 - 3 of 3
Head Neck Cancer, Head and Neck Tumors Trial run by the NCI (M7824, N803, TriAd vaccine)
Active, not recruiting
- Head and Neck Cancer
- Head and Neck Neoplasms
- M7824
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
NonHodgkin's Lymphoma Refractory Trial in El Segundo (N803, CD19t-haNK suspension, Cyclophosphamide)
Not yet recruiting
- NonHodgkin's Lymphoma Refractory
- N803
- +4 more
-
El Segundo, CaliforniaCSSIFM
Nov 9, 2022
Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)
Not yet recruiting
- Human Immunodeficiency Virus
- 3BNC117-LS
- +2 more
-
New York, New York
- +2 more
Jul 12, 2022